Navigation Links
BioPlus Specialty Pharmacy Selected by MedImpact as One of Its ChoiceSpecialty® Pharmacies
Date:10/23/2013

Altamonte Springs, FL (PRWEB) October 23, 2013

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading specialty pharmacies, became a ChoiceSpecialty provider for MedImpact Healthcare Systems, Inc. as of September 1, 2013, and one of the preferred pharmacy providers of hepatitis C medications to MedImpact’s members. MedImpact is the nation’s largest privately held provider of pharmacy benefit management (PBM) services.

Specialty pharmacies provide access to intravenous, oral, and injectable medications needed for hepatitis C, bleeding disorders, cancer, arthritis, and other chronic diseases. Typically, access to these types of medications is limited and not often available at local drug stores.

“What I’m excited about with our new relationship with MedImpact is the opportunity to fully collaborate with them to provide the highest-quality care to their clients’ members, going far beyond a simple vendor relationship,” states Murali Sastry, Director of Managed Care for BioPlus. “In addition to being a preferred provider in their specialty pharmacy network, BioPlus’ new role as one of MedImpact’s preferred specialty pharmacies for hepatitis C allows us to provide the members with our Best in Class hepatitis C program, which has a proven track record of enhancing patient outcomes,” explains Sastry. BioPlus’ hepatitis C program includes an initial consult with a Doctor of Pharmacy for every patient starting a new therapy to educate the patient about the medication protocol and provide a detailed explanation of the plan of care, home delivery of medications, hands-on injection training with a nurse, and a medication dose reminder system.

“We are very pleased with the excitement around BioPlus’ RxSteward Program, which is designed to reduce unnecessary drug utilization while maintaining our excellent clinical outcomes,” shares Russell Gay, Chief Strategic Officer at BioPlus. “Sponsors and plans will have new high-touch options through the collaboration of MedImpact and BioPlus, particularly as new high-cost biologics are introduced for hepatitis C, oncology, and other specialty therapies,” adds Gay.

About BioPlus Specialty Pharmacy

BioPlus is a pharmacist-owned, national specialty pharmacy providing high-touch services and specialty pharmaceuticals for bleeding disorders, cancer, hepatitis C, immune deficiencies, neuromuscular disorders, and other complex, chronic conditions. BioPlus is licensed in all 50 states and accredited by URAC, VIPPS, and Accreditation Commission for Health Care (ACHC). BioPlus is one of the nation’s largest independent specialty pharmacies; patients can contact the pharmacy toll free at 1-866-514-8082.

About MedImpact Healthcare Systems, Inc.

MedImpact Healthcare Systems, Inc. (http://www.medimpact.com), founded in 1989 and headquartered in San Diego, CA, is a PBM that combines subject matter expertise with innovative technology and services to deliver better healthcare outcomes and improve its clients’ positions in the market. MedImpact provides PBM services to 47 million members of health plans, hospitals, and employers in the U.S. and abroad. MedImpact’s model is unique: avoiding conflict of interest by deriving revenue from effectively managing client pharmacy benefits rather than dispensing drugs.

For information: http://www.bioplusrx.com or
Contact: info(at)bioplusrx(dot)com
Phone: 1-888-292-0744

Read the full story at http://www.prweb.com/releases/2013/10/prweb11261174.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. BioPlus Specialty Pharmacy Now a Participating Provider for the BlueCross BlueShield of Tennessee’s Specialty Pharmacy Network
2. ‘2-Hour Patient Acceptance Guarantee’ Program from BioPlus Specialty Pharmacy Rolls Out to Enthusiastic Physician and Patient Response
3. BioPlus Specialty Pharmacy Founder and CEO Selected as Finalist in Ernst & Young Florida Entrepreneur of the Year Award
4. Specialty Chemicals Market (Crude Oil, Naphtha, Ethane, Propane, Butane) Worth $ 610.14 Billion by 2016 - New Report by MarketsandMarkets
5. TheHardwareCity.com Displays the Specialty Item, Broan-NuTone College Pride Doorbell Mechanism in Their Catalog
6. Probiotics Market (Functional Foods, Dietary Supplements, Specialty Nutrients, Animal Feed) Worth $23.93 Billion by 2017 - New Report by MarketsandMarkets
7. Specialty Chocolate Stores in Australia Industry Market Research Report Now Updated by IBISWorld
8. Global Specialty Chemicals Market (Product Type, Functional Type, Key Applications, Raw Materials) Worth $ 610.14 Billion by 2016 - New Report by MarketsandMarkets
9. LDM and gMed Partner to Bring Clinically Relevant Healthcare Messages to Patients and Specialty Specific EHR Providers
10. Dr. Grady Core Speaks at The Multi-Specialty Symposium in Las Vegas
11. TheHardwareCity.com Offers A Specialty Aquarium Toilet Seat Manufactured by Jones Stephens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Journal of Oral Implantology ... have severe consequences to overall dental health, including complications with speech, eating, and overcompensation ... dental implants to replace lost teeth. As the number of tooth replacements increase, it ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... Hackensack, N.J. has been honored by Enterprising Women magazine as one of its ... world’s top women business owners. Winners have demonstrated that they have fast-growth businesses, ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... RawTrition now ... easy way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients ... the cellular level because the body recognizes its raw form (unlike the synthetically made ...
(Date:4/26/2017)... ... 26, 2017 , ... MYOLYN, a medical technology company dedicated ... received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two ... devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and ... its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... , April 24, 2017 Solentim, the ... announced the addition of a major new product ... Plate Seeding,). The VIPS has been developed for ... well microplates as part of the process to ... a simple and more reliable solution when compared ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Addressing Production Complexities Through Risk Management and Quality by ... ... Market Prospects: Overcoming Production Complexities Through Risk Management and ... current trends in the global biosimilars market, with a ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: